Ontrak Inc. Announces $4 Million Public Offering of Common Stock and Warrants

Reuters
Jul 04
Ontrak Inc. Announces $4 Million Public Offering of Common Stock and Warrants

Ontrak, Inc., a leader in value-based behavioral healthcare powered by AI and engagement technology, has announced the pricing of a $4 million public offering. The offering includes 6,666,667 shares of common stock and 26,666,668 warrants to purchase additional shares at $0.60 per share and accompanying warrants. Roth Capital Partners, LLC is serving as the exclusive placement agent for the offering. The exercisability of the warrants, each priced at $0.60, is subject to stockholder approval and will expire on the fifth anniversary of such approval. The offering is anticipated to close on or around June 30, 2025, pending customary closing conditions. Acuitas Group Holdings, LLC and Acuitas Capital LLC have agreed to support the exercisability of the warrants, and will hold a majority of the common stock before the offering's closure.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ontrak Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-034303), on July 03, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10